CARE reaffirms assigned ‘A1+’ rating to CP Programme of Elder Pharmaceuticals

29 Jul 2011 Evaluate

Credit rating agency, CARE has reaffirmed the assigned ‘A1+’ rating to Commercial Paper (CP) Programme carved out of WC limits of Elder Pharmaceuticals for Rs 105.00 crore. The agency has also reaffirmed the assigned ‘A1+’ rating to Commercial Paper (standalone) Programme of the company for Rs 75.00 crore.

Improvement in the overall capital structure in terms of the reduction in gearing ratios and shortening of the working capital cycle are the key rating sensitivities.

Elder Pharmaceuticals (EPL) is engaged in the manufacturing and marketing of mainly pharmaceutical formulations, under its own as well as in-licensed brands, and offers a gamut of products in the Active Pharmaceutical Ingredients (API)/bulk drugs. The company is also a distributor of the cosmeceutical products.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×